{"transactions":[{"id":963193,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-18T17:47:02.000Z","date":"2025-12-16","kind":"other","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-25-028392","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315225028392/ownership.xml","form_type":"4"}},{"id":1324163,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Stock Options","published_at":"2024-12-20T20:33:13.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027."}],"balance_after":75000,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-051144","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315224051144/ownership.xml","form_type":"4"}},{"id":1719113,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Stock Options","published_at":"2023-12-07T17:05:58.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026."}],"balance_after":100000,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-23-044057","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315223044057/ownership.xml","form_type":"4"}},{"id":2488852,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Stock Options","published_at":"2021-12-02T18:26:24.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":265700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024."}],"balance_after":265700,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":265700},"source":{"system":"sec-edgar","filing":"0001493152-21-030333","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315221030333/ownership.xml","form_type":"4"}},{"id":2488851,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-02T18:26:24.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted 100,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve."}],"balance_after":101600,"source":{"system":"sec-edgar","filing":"0001493152-21-030333","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315221030333/ownership.xml","form_type":"4"}},{"id":2697050,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-25T17:15:44.000Z","date":"2021-05-21","kind":"purchase","acquired":true,"shares":1600,"price":5.9,"value":9440.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 21, 2021, the reporting person purchased 1,600 shares of common stock on the open market at $5.90 per share."}],"balance_after":1600,"source":{"system":"sec-edgar","filing":"0001493152-21-012878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315221012878/ownership.xml","form_type":"4"}},{"id":2843396,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CMO"}}],"security":"Stock Option","published_at":"2021-02-22T21:56:07.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":406000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in equal quarterly installments over a two a year period, however the stock options may only become exercisable following receipt by the registrant of stockholder approval to increase the size of the Plan sufficiently to permit the exercise in full of such stock options under the Plan. If the registrant's stockholders do not approve an increase in the size of the Plan, the options will be void."}],"balance_after":406000,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":406000},"source":{"system":"sec-edgar","filing":"0001493152-21-004528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315221004528/ownership.xml","form_type":"4"}},{"id":3078795,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CMO"}}],"security":"Stock Option","published_at":"2020-07-21T21:58:00.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on July 18, 2020. The award is subject to time-based vesting and will vest in equal monthly portions over three years."}],"balance_after":1000000,"derivative":{"exercise_price":0.4,"expiration_date":"2030-07-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-20-013755","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315220013755/ownership.xml","form_type":"4"}},{"id":3453334,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Senior Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T17:44:05.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest quarterly over a three (3) year period commencing on July 26, 2019."}],"balance_after":180000,"derivative":{"exercise_price":2,"expiration_date":"2029-07-26","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001493152-19-011362","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315219011362/ownership.xml","form_type":"4"}},{"id":3453333,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Senior Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T17:44:05.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":184500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on October 1, 2016, and provides that the options will have vested over a period of 2 years, with 1/5th of the shares subject to the option vested on October 1, 2016, and with the remaining shares vesting in equal monthly installments over the 24 months thereafter."}],"balance_after":184500,"derivative":{"exercise_price":2,"exercise_date":"2019-07-26","expiration_date":"2026-10-01","underlying":"Common Stock","underlying_shares":184500},"source":{"system":"sec-edgar","filing":"0001493152-19-011362","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315219011362/ownership.xml","form_type":"4"}},{"id":3453332,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Senior Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T17:44:05.000Z","date":"2019-07-26","kind":"disposition_to_issuer","acquired":false,"shares":184500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on October 1, 2016, and provides that the options will have vested over a period of 2 years, with 1/5th of the shares subject to the option vested on October 1, 2016, and with the remaining shares vesting in equal monthly installments over the 24 months thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on October 1, 2016, and provides that the options will have vested over a period of 2 years, with 1/5th of the shares subject to the option vested on October 1, 2016, and with the remaining shares vesting in equal monthly installments over the 24 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2026-10-01","underlying":"Common Stock","underlying_shares":184500},"source":{"system":"sec-edgar","filing":"0001493152-19-011362","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315219011362/ownership.xml","form_type":"4"}}]}